Ñî¹óåú´«Ã½Ò•îl

A new study offers a new and unique treatment for AIDS which may be developed into a vaccine or a one-time treatment for patients with HIV. (Tel Aviv University, 6/14)

A systematic review and analysis of studies on pregnant women with multidrug-resistant tuberculosis (MDR-TB) found some encouraging results, researchers reported late last week in JAMA Network Open. (6/13)

The monoclonal-antibody combination AZD7442 is composed of tixagevimab and cilgavimab, two neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that have an extended half-life and have been shown to have prophylactic and therapeutic effects in animal models. Pharmacokinetic data in humans indicate that AZD7442 has an extended half-life of approximately 90 days. (Levin, M.D., et al, 6/9)

Implementation of policy measures in March 2020 in Canada stemmed prescription drug shortages—especially generic drugs—exacerbated by the COVID-19 pandemic, finds an observational study published today in the Canadian Medical Association Journal (CMAJ). ... The authors acknowledged that the reduction in shortages may have stemmed from factors other than the policy changes, such as fewer healthcare visits and reduced demand for drugs amid pandemic restrictions. (Van Beusekom, 6/13)

The cost of prescription drugs in the U.S. can be enough to make you sick. What you pay varies enormously depending on the drug, the pharmacy, your insurance plan and your deductible, among many other factors. A drug that may have been cheap or at least affordable the last time you filled it could be far more expensive or not covered at all the next time. (Lis Weston, 6/13)

Two Kendall men spent seven years — not even pausing during the two years one of them was in prison — raking in $9 million in a scam involving coupons meant to help people pay for prescription drugs. They used friends, wives of friends, shell companies and pharmacies that existed only on paper. (Neal, 6/12)